These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24721998)

  • 41. HIV transmitted drug resistance in adult and pediatric populations in Panama.
    Castillo J; Arteaga G; Mendoza Y; Martínez AA; Samaniego R; Estripeaut D; Page KR; Smith RE; Sosa N; Pascale JM
    Rev Panam Salud Publica; 2011 Dec; 30(6):649-56. PubMed ID: 22358417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transmission dynamics of HIV-1 subtype B in the Basque Country, Spain.
    Patiño-Galindo JA; Thomson MM; Pérez-Álvarez L; Delgado E; Cuevas MT; Fernández-García A; Nájera R; Iribarren JA; Cilla G; López-Soria L; Lezaun MJ; Cisterna R; González-Candelas F;
    Infect Genet Evol; 2016 Jun; 40():91-97. PubMed ID: 26921800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs.
    Alteri C; Svicher V; Gori C; D'Arrigo R; Ciccozzi M; Ceccherini-Silberstein F; Selleri M; Bardacci SA; Giuliani M; Elia P; Scognamiglio P; Balzano R; Orchi N; Girardi E; Perno CF;
    BMC Infect Dis; 2009 Jul; 9():111. PubMed ID: 19607681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and outcomes of recycling NNRTIs despite documented NNRTI resistance in HIV-infected children and youth.
    Agwu AL; Chang JY; Wiegand RE; Wheeling JT; Bohannon BA; Dominguez KL;
    AIDS Patient Care STDS; 2014 Jan; 28(1):10-4. PubMed ID: 24428795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.
    Whitcomb JM; Huang W; Limoli K; Paxinos E; Wrin T; Skowron G; Deeks SG; Bates M; Hellmann NS; Petropoulos CJ
    AIDS; 2002 Oct; 16(15):F41-7. PubMed ID: 12370521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sexual violence among two populations of men at high risk of HIV infection.
    Braitstein P; Asselin JJ; Schilder A; Miller ML; Laliberté N; Schechter MT; Hogg RS
    AIDS Care; 2006 Oct; 18(7):681-9. PubMed ID: 16971275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and patterns of HIV transmitted drug resistance in Guatemala.
    Avila-Ríos S; Mejía-Villatoro CR; García-Morales C; Soto-Nava M; Escobar I; Mendizabal R; Girón A; García L; Reyes-Terán G
    Rev Panam Salud Publica; 2011 Dec; 30(6):641-8. PubMed ID: 22358416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
    Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
    Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M
    Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance-associated mutations and polymorphisms in NNRTI-naïve HIV-infected patients.
    Clevenbergh P; Cua E; Dam E; Durant J; Schmit JC; Boulme R; Cottalorda J; Beyou A; Schapiro JM; Clavel F; Dellamonica P
    HIV Clin Trials; 2002; 3(1):36-44. PubMed ID: 11819184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
    Descamps D; Assoumou L; Chaix ML; Chaillon A; Pakianather S; de Rougemont A; Storto A; Dos Santos G; Krivine A; Delaugerre C; Montes B; Izopet J; Charpentier C; Wirden M; Maillard A; Morand-Joubert L; Pallier C; Plantier JC; Guinard J; Tamalet C; Cottalorda J; Marcelin AG; Desbois D; Henquell C; Calvez V; Brun-Vézinet F; Masquelier B; Costagliola D;
    J Antimicrob Chemother; 2013 Nov; 68(11):2626-31. PubMed ID: 23798669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009.
    Youmans E; Tripathi A; Albrecht H; Gibson JJ; Duffus WA
    South Med J; 2011 Feb; 104(2):95-101. PubMed ID: 21206421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The prevalence of primary HIV-1 drug resistance in newly reported HIV infections in Henan].
    Liu J; Xu W; He C; Yan J; Xing H; Xue XJ; Sun DY; Zhu Q; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 May; 37(5):643-7. PubMed ID: 27188354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expanding HIV-1 subtype B transmission networks among men who have sex with men in Poland.
    Parczewski M; Leszczyszyn-Pynka M; Witak-Jędra M; Szetela B; Gąsiorowski J; Knysz B; Bociąga-Jasik M; Skwara P; Grzeszczuk A; Jankowska M; Barałkiewicz G; Mozer-Lisewska I; Łojewski W; Kozieł K; Grąbczewska E; Jabłonowska E; Urbańska A
    PLoS One; 2017; 12(2):e0172473. PubMed ID: 28234955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transmitted human immunodeficiency virus-1 drug resistance in a cohort of men who have sex with men in Belo Horizonte, Brazil--1996-2012.
    Tupinambás U; Duani H; Martins AV; Aleixo AW; Greco DB
    Mem Inst Oswaldo Cruz; 2013 Jun; 108(4):470-5. PubMed ID: 23828000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort.
    Machnowska P; Meixenberger K; Schmidt D; Jessen H; Hillenbrand H; Gunsenheimer-Bartmeyer B; Hamouda O; Kücherer C; Bannert N;
    PLoS One; 2019; 14(1):e0209605. PubMed ID: 30650082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transmitted, pre-treatment and acquired antiretroviral drug resistance among men who have sex with men and transgender women living with HIV in Nigeria.
    Crowell TA; Kijak GH; Sanders-Buell E; O'Sullivan AM; Kokogho A; Parker ZF; Lawlor J; Polyak CS; Adebajo S; Nowak RG; Baral SD; Robb ML; Charurat ME; Ake JA; Ndembi N; Tovanabutra S;
    Antivir Ther; 2019; 24(8):595-601. PubMed ID: 32125280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14.
    Fabeni L; Alteri C; Di Carlo D; Orchi N; Carioti L; Bertoli A; Gori C; Forbici F; Continenza F; Maffongelli G; Pinnetti C; Vergori A; Mondi A; Ammassari A; Borghi V; Giuliani M; De Carli G; Pittalis S; Grisetti S; Pennica A; Mastroianni CM; Montella F; Cristaudo A; Mussini C; Girardi E; Andreoni M; Antinori A; Ceccherini-Silberstein F; Perno CF; Santoro MM; ;
    J Antimicrob Chemother; 2017 Oct; 72(10):2837-2845. PubMed ID: 29091206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.